# Clinical Study of Escitalopram Oxalate Combined With taVNS in Depression and Concomitant Inflammatory Symptoms

> **NCT04037111** · NA · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Major Depressive Disorder
- Rheumatoid Arthritis

## Interventions

- **DEVICE:** Transcutaneous electrical vagus nerve stimulation
- **DEVICE:** Sham vagus nerve stimulation
- **DRUG:** drug treatment

## Key facts

- **NCT ID:** NCT04037111
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-23
- **Primary completion:** 2021-01
- **Final completion:** 2021-12
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2019-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04037111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04037111, "Clinical Study of Escitalopram Oxalate Combined With taVNS in Depression and Concomitant Inflammatory Symptoms". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04037111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*